49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details


臨床試験数 : 993 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02102594
(ClinicalTrials.gov)
October 201425/3/2014Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)Myasthenia Gravis;Systemic Lupus Erythematosus;Rheumatoid ArthritisDrug: BortezomibCharite University, Berlin, GermanyProf. Dr. med. Falk Hiepe (Charité, Internal Medicine / Rheumathology);NeuroCure Clinical Research Center, Charite, BerlinTerminated18 Years75 YearsAll11Phase 2Germany
2JPRN-UMIN000012227
2013/11/0606/11/2013A phase II randomized trial of evaluation for boltezomib in refractory Systemic lupus erythematosusA phase II randomized trial of evaluation for boltezomib in refractory Systemic lupus erythematosus - A phase II randomized trial of evaluation for boltezomib in refractory Systemic lupus erythematosus Systemic lupus erythmatosusbortezomib(1.3mg/m2)
2times/week total 8times.
saline
Tohoku university hospitalNULLComplete: follow-up complete20years-old65years-oldMale and Female14Phase 2Japan